Flow cytometric analysis of CD155/PVR expression on human peripheral blood cells. Human peripheral blood cells were stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Left panel) or SDT Alexa Fluor® 647 Mouse Anti-Human CD155/PVR Antibody (Right panel) at 1.25 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD155/PVR |
Synonyms | Poliovirus receptor; Nectin-like protein 5 (NECL-5); PVS |
Location | Cell membrane |
Accession | P15151 |
Clone Number | S-2901 |
Antibody Type | Mouse mAb |
Isotype | IgG1,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | human peripheral blood cells |
Purification | Protein G |
Concentration | 0.2 mg/ml |
Conjugation | Alexa Fluor® 647 |
Physical Appearance | Liquid |
Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
FCM | 1.25μl per million cells in 100μl volume | Hu |
Background
CD155, also designated PVR (poliovirus receptor) and Necl-5, is a ~70 kDa primate-restricted type I transmembrane glycoprotein of the immunoglobulin superfamily that contains one V-type and two C2-type extracellular Ig-like domains, a 24-aa transmembrane segment and a 50-aa cytoplasmic tail; it serves as the cellular entry receptor for poliovirus, mediates cell adhesion by binding vitronectin and nectin-3, and engages immune receptors DNAM-1/CD226, CD96 and TIGIT to regulate NK-cell cytotoxicity, T-cell activation and tumor-cell recognition, while its expression—up-regulated by IFN-γ on endothelial cells and abundant on immature thymocytes, dendritic cells and epithelial/neuronal tumor cells—promotes cell migration, loss of contact inhibition and transendothelial migration.
Picture
Picture
FC
